You are here

CGRP blockers

FDA expands Qulipta indication to include chronic migraine prevention

Healio

Tue, 04/18/23 - 10:13 pm

Teva’s CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial

BioSpace

Thu, 08/22/19 - 11:06 am

Teva Pharmaceutical

clinical trials

Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A

Fierce Pharma

Fri, 07/12/19 - 09:50 am

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

Xconomy

Sat, 05/4/19 - 04:54 pm

Teva Pharmaceutical

Lilly claims fast FDA review for Emgality in cluster headache

Pharmaforum

Tue, 03/5/19 - 11:55 am

episodic cluster headache

Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical

Fierce Pharma

Mon, 01/14/19 - 11:11 am

Teva Pharmaceutical

Don't fret about Lilly's 3rd-to-market start in CGRP, exec says. It's got big plans in migraine and pain, too

Fierce Pharma

Wed, 01/9/19 - 09:38 am

Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei

Endpoints

Tue, 03/13/18 - 10:13 am

Teva Pharmaceutical

drug development

Heptares Therapeutics

In latest blow to Teva, CGRP migraine med delayed while rivals race towards the finish line

Endpoints

Thu, 02/8/18 - 09:40 am

Teva Pharmaceutical

Amgen pulls ahead in sprint towards CGRP approval with promising PhIII migraine data

Endpoints

Wed, 11/29/17 - 09:44 pm

Amgen And Novartis: First Mover Advantage Is A Must

Seeking Alpha

Mon, 07/24/17 - 11:55 pm

With late-stage data in on the CGRP migraine drug erenumab, Novartis and Amgen rework commercialization pact

Endpoints

Tue, 04/25/17 - 11:03 am

Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field

Endpoints

Thu, 09/29/16 - 08:23 am

The drug industry might finally have an answer for migraines

Stat

Fri, 09/23/16 - 09:52 am

Alder Biopharma

Teva Pharmaceutical